🔊 A cough might reveal more than we think…
Yesterday at EMBC 2025 in Copenhagen, Chiara Giangregorio (Politecnico di Milano) took the stage to present her team’s work on automatic cough analysis for non-small cell lung cancer detection.
A bold and forward-thinking approach that brings together AI, biomedical engineering, and a simple question: can something as ordinary as a cough become a tool for early diagnosis?
💙 A big thank you to everyone involved in this presentation and to the entire team working alongside Chiara to drive innovation forward within I3LUNG.
Onwards!
In this video, Anniina Hentinen from Lung Cancer Europe breaks down what AI really means for patients:
🧠 AI analyzes huge amounts of data to support faster diagnoses, better treatment decisions, and personalized care.
🤖 But AI provides insights. Doctors make decisions. Patients stay at the heart.
AI isn’t here to take over. It’s here to help people get the care they deserve. 🫰🏻
Watch the video here!
Chiara Giangregorio decodes data patterns.
Valeria Sebri brings in the psychological layer.
Together, they turn raw data into insights that actually make sense for patients’ lives. 🙌🏻
👀 Watch the video here
Vanja Mišković Miskovic from Politecnico di Milano brought this question to the stage at the AI in Oncology by IHU PRISM in Paris, representing the I3LUNG Project. In her presentation: “Multimodal XAI in Clinical Oncology: Toward Transparent and Trustworthy AI Tools”, she explored how explainable AI, integrating diverse clinical data that can move us closer to tools that not only predict, but also support care teams in meaningful, reliable ways.
Dr. Raquel Perez-Lopez, one of the co-founders of this initiative, is capturing the dynamic spirit and mission behind the event.
In her talk, she also guided us through an in-depth exploration of the opportunities and challenges of AI in radiology, especially in the context of precision medicine.
Watch the video here!
A newly founded multidisciplinary scientific society with one clear mission: to ensure the proper, accurate, and transparent implementation of Artificial Intelligence in cancer research.
Born from the collaboration of I3LUNG partners and other leading experts across Europe, ESAC is one of the first bold steps toward transforming how AI supports oncology from lab to clinic. 🏥✨
Watch de video here!
The I3LUNG partners Dr. Helena Linardou, Arsela Prelaj, and Marina Chiara Garassino proudly opened the Summer School on AI in Cancer Research, organized by ESAC – European Interdisciplinary Society of AI for Cancer Research in collaboration with HeCOG-Hellenic Cooperative Oncology Group, Metropolitan Hospital, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, and Technische Universität Dresden.
Kicking off yesterday, this week-long program brings together over 35 students for hands-on workshops on machine learning in medical imaging, predictive modeling, and big data in oncology.
This is how we forge the future of AI in cancer care, by empowering the next generation of innovators.
📩 Want to be part of the next edition? Reach out: info@i3lung.eu
👉🏼 Watch the video here!
For the third consecutive year, the 16 partners of the I3LUNG consortium, an EU-funded project under the Horizon 2020 programme, gather for their annual meeting to share progress and reinforce their position as pioneers in the application of artificial intelligence (AI) in oncology.
I3LUNG represents a disruptive leap forward in the fight against lung cancer. The project has a clear objective: to develop an AI-based tool that empowers oncologists and patients to jointly select the most suitable treatment in a personalized manner.
By integrating clinical and molecular data from lung cancer patients and developing a machine learning algorithm, I3LUNG is building a predictive system that anticipates individual responses to existing therapies. This tool aims thereby to recommend tailored treatments for each patient, shortening decision-making timelines, minimizing the chances of disease progression, and only proposing the necessary exams and analyses while reducing toxicities and adverse effects, all with one key goal: improving patients’ quality of life.
I3LUNG: Innovation with real-world impact
The project is driving transformation across the board:
- For oncologists, it offers a decision-support tool powered by a robust database, with insights that will be made accessible to the wider research community, enhancing and personalizing clinical judgment.
- For patients, it reduces the time between diagnosis and treatment, minimizes side effects, and keeps the focus on recovery. A dedicated patients co-decision tool (IPDAS) is already available in a validated prototype version, with information on the disease, treatment options and their associated survival and quality of life assessments.
- From a health economics perspective, it supports more efficient resource allocation within healthcare systems and reduces costs associated with ineffective or misdirected treatments.
If the algorithm’s effectiveness is confirmed, final results are expected by May 2027, this solution could be extended to other tumor types.
Partners driving change
Launched in June 2022, I3LUNG is one of several projects positioning the consortium as a European leader in AI-driven oncology. Its principal investigator, Dr. Arsela Prelaj, a medical oncologist at the Istituto Nazionale dei Tumori, is spearheading several initiatives stemming from the project, including:
- ESAC (European Society of Artificial Intelligence in Cancer): The first multidisciplinary European society focused on AI in cancer, founded in March 2025 to foster collaboration among oncologists, imaging specialists, scientists, bioinformaticians, and engineers with AI expertise. The Society involves key leaders in the field, representing other EU scientific societies and large research infrastructures – it is presided by Arsela, prof. Jakob Kather as its president-elect, and with our greek partner Helena Linardou as its treasurer.
- Organization of the first European Summer School on AI for Oncology hosted by I3LUNG partner Metropolitan Hospital of Athens: a training program that brings together young researchers and international experts to accelerate knowledge transfer and cultivate the next generation of AI leaders in oncology. Several I3LUNG partners compose the faculty of this event, the first under ESAC’s umbrella (H. Linardou, A. Prelaj, S. Kosta, M. Garassino, A. Pearson, M. Reck, E. Felip).
With its first actionable results achieved, I3LUNG has reached out to other EU initiatives in the oncology AI area – and the new steps in the broader data sharing framework in Europe (EHDS): SHAIPED, EUCAIM, and more. This year, Dr. Prelaj has also been invited as a keynote speaker at the World Conference on Lung Cancer (WCLC), one of the world’s foremost events in lung cancer. Alongside other consortium members, she will participate in the inaugural edition of ESMO AI, a new congress organized by the European Society for Medical Oncology, taking place in October in Berlin, focused entirely on AI’s clinical, research, and regulatory applications in oncology.
I3LUNG is moving steadily from theory to practice, laying the foundations for a future in which artificial intelligence becomes a key ally in enhancing clinical decision-making, personalized medicine, while empowering patients in the management of their disease. In conclusion, I3LUNG stands out as one of Europe’s most ambitious and inspiring projects at the intersection of science, technology and health.
This year’s meeting has been packed with bold ideas 💡, honest debates 🗣️, and collaborative energy 🤝, all driving us toward a stronger, smarter, and more impactful project 🚀. We’ve worked hard 💼, thought harder 🤯, and yes… definitely enjoyed Corfu.
So… what’s next? 👀
We’ll meet again next year. Same spirit, new backdrop.
Hint: Northern vibes, cooler temps, and some pretzels…
Watch the video here!
Thank you all for your collaboration 🎥:
Matteo Sacco Silvia Flor Arnal A. Halid Kayhan Anniina Hentinen Vanja Mišković Natacha Bonnet Eylem Karakaya Maria Marín Vilar, PhD Alexander Pearson Margherita Favali Giovanni Scoazec
Arsela Prelaj Helena Linardou Marina Chiara Garassino Martin Reck Nir Peled Enriqueta Felip
We’ve lost count of how many languages are spoken across our I3LUNG Consortium, but one thing’s for sure: collaboration is our common language⭐️
Here’s a little hello from every corner of the world! 🌍👋
Thank you all for your collaboration 🎥:
Natacha Bonnet Michael Willis Francesco Trovò Giovanni Scoazec Anniina Hentinen Sokol Kosta Aina A. A. Halid Kayhan Eylem Karakaya
Watch the video here!